These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31422281)

  • 1. Lesser motor disability in adulthood: A ten-year follow-up of a dyskinetic patient with ADCY5 mutation.
    Kawarai T; Orlacchio A; Kaji R
    J Neurol Sci; 2019 Oct; 405():116383. PubMed ID: 31422281
    [No Abstract]   [Full Text] [Related]  

  • 2. Child Neurology: Spastic paraparesis and dystonia with a novel
    Dean M; Messiaen L; Cooper GM; Amaral MD; Rashid S; Korf BR; Standaert DG
    Neurology; 2019 Sep; 93(11):510-514. PubMed ID: 31501304
    [No Abstract]   [Full Text] [Related]  

  • 3. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.
    Chen YZ; Friedman JR; Chen DH; Chan GC; Bloss CS; Hisama FM; Topol SE; Carson AR; Pham PH; Bonkowski ES; Scott ER; Lee JK; Zhang G; Oliveira G; Xu J; Scott-Van Zeeland AA; Chen Q; Levy S; Topol EJ; Storm D; Swanson PD; Bird TD; Schork NJ; Raskind WH; Torkamani A
    Ann Neurol; 2014 Apr; 75(4):542-9. PubMed ID: 24700542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia.
    Douglas AG; Andreoletti G; Talbot K; Hammans SR; Singh J; Whitney A; Ennis S; Foulds NC
    Neurogenetics; 2017 Apr; 18(2):111-117. PubMed ID: 28229249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5.
    Chen YZ; Matsushita MM; Robertson P; Rieder M; Girirajan S; Antonacci F; Lipe H; Eichler EE; Nickerson DA; Bird TD; Raskind WH
    Arch Neurol; 2012 May; 69(5):630-5. PubMed ID: 22782511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.
    Carapito R; Paul N; Untrau M; Le Gentil M; Ott L; Alsaleh G; Jochem P; Radosavljevic M; Le Caignec C; David A; Damier P; Isidor B; Bahram S
    Mov Disord; 2015 Mar; 30(3):423-7. PubMed ID: 25545163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous ADCY5 mutation causes early-onset movement disorder with severe intellectual disability.
    Okamoto N; Miya F; Kitai Y; Tsunoda T; Kato M; Saitoh S; Kanemura Y; Kosaki K
    Neurol Sci; 2021 Jul; 42(7):2975-2978. PubMed ID: 33704598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series.
    Dy ME; Chang FC; Jesus SD; Anselm I; Mahant N; Zeilman P; Rodan LH; Foote KD; Tan WH; Eskandar E; Sharma N; Okun MS; Fung VS; Waugh JL
    J Child Neurol; 2016 Jul; 31(8):1027-35. PubMed ID: 27052971
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kamate M; Mittal N
    Neurol India; 2018; 66(Supplement):S141-S142. PubMed ID: 29503338
    [No Abstract]   [Full Text] [Related]  

  • 10. An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.
    Ferrini A; Steel D; Barwick K; Kurian MA
    Mov Disord; 2021 May; 36(5):1104-1114. PubMed ID: 33934385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
    Carecchio M; Mencacci NE; Iodice A; Pons R; Panteghini C; Zorzi G; Zibordi F; Bonakis A; Dinopoulos A; Jankovic J; Stefanis L; Bhatia KP; Monti V; R'Bibo L; Veneziano L; Garavaglia B; Fusco C; Wood N; Stamelou M; Nardocci N
    Parkinsonism Relat Disord; 2017 Aug; 41():37-43. PubMed ID: 28511835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and psychosis in ADCY5-related dyskinesia-part of the phenotypic spectrum?
    Vijiaratnam N; Newby R; Kempster PA
    J Clin Neurosci; 2018 Nov; 57():167-168. PubMed ID: 30172639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.
    Bohlega SA; Abou-Al-Shaar H; AlDakheel A; Alajlan H; Bohlega BS; Meyer BF; Monies D; Cupler EJ; Al-Saif AM
    Parkinsonism Relat Disord; 2019 Jul; 64():145-149. PubMed ID: 30975617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic insights into ADCY5-associated disease.
    Chang FC; Westenberger A; Dale RC; Smith M; Pall HS; Perez-Dueñas B; Grattan-Smith P; Ouvrier RA; Mahant N; Hanna BC; Hunter M; Lawson JA; Max C; Sachdev R; Meyer E; Crimmins D; Pryor D; Morris JG; Münchau A; Grozeva D; Carss KJ; Raymond L; Kurian MA; Klein C; Fung VS
    Mov Disord; 2016 Jul; 31(7):1033-40. PubMed ID: 27061943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing.
    Zech M; Jech R; Wagner M; Mantel T; Boesch S; Nocker M; Jochim A; Berutti R; Havránková P; Fečíková A; Kemlink D; Roth J; Strom TM; Poewe W; Růžička E; Haslinger B; Winkelmann J
    Neurogenetics; 2017 Dec; 18(4):195-205. PubMed ID: 28849312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADCY5-related dyskinesia - case series with literature review.
    Kozon K; Łysikowska W; Olszewski J; Milanowski Ł; Figura M; Mazurczak T; Hoffman-Zacharska D; Koziorowski D
    Neurol Neurochir Pol; 2024; 58(2):161-166. PubMed ID: 38230756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADCY5 identified as a novel cause of benign hereditary chorea.
    Raj Kumar K; Fung VS
    Mov Disord; 2015 Nov; 30(13):1726. PubMed ID: 26408352
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
    Méneret A; Mohammad SS; Cif L; Doummar D; DeGusmao C; Anheim M; Barth M; Damier P; Demonceau N; Friedman J; Gallea C; Gras D; Gurgel-Giannetti J; Innes EA; Necpál J; Riant F; Sagnes S; Sarret C; Seliverstov Y; Paramanandam V; Shetty K; Tranchant C; Doulazmi M; Vidailhet M; Pringsheim T; Roze E
    Mov Disord; 2022 Jun; 37(6):1294-1298. PubMed ID: 35384065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.
    Méneret A; Gras D; McGovern E; Roze E
    Ann Intern Med; 2019 Sep; 171(6):439. PubMed ID: 31181574
    [No Abstract]   [Full Text] [Related]  

  • 20. ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.
    Friedman JR; Méneret A; Chen DH; Trouillard O; Vidailhet M; Raskind WH; Roze E
    Mov Disord; 2016 Jan; 31(1):147-8. PubMed ID: 26686870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.